← Back to guidelines
Cardiology18 papers

Propionibacterium infection

Last edited: 4/22/2026

Overview

Propionibacterium infections encompass a range of clinical presentations, often involving deep tissue infections and abscesses, though specific neurological complications like those seen in metabolic disorders (e.g., propionic acidaemia) can also occur 1.

Diagnosis

  • Clinical Presentation: Symptoms may include localized pain, swelling, and fever for soft tissue infections 1.
  • Laboratory Tests: Elevated white blood cell count, C-reactive protein, and imaging studies (e.g., MRI, CT) for abscess identification 1.
  • Culture and Sensitivity: Essential for confirming Propionibacterium species and guiding antibiotic therapy 1.
  • Management

  • First-Line Treatment: Penicillin or ampicillin are often used initially, though susceptibility testing is crucial 1.
  • Adjunctive Therapies: Drainage of abscesses when indicated, and in specific cases, supportive treatments like L-DOPA for extrapyramidal symptoms 1.
  • Special Populations

  • Pediatrics: Neurological complications in metabolic disorders like propionic acidaemia require careful monitoring and specific symptomatic treatment (e.g., L-DOPA) 1.
  • Key Recommendations

  • Confirm diagnosis through culture and sensitivity testing for appropriate antibiotic selection (Evidence: Moderate 1).
  • Consider surgical drainage for abscesses in conjunction with antibiotic therapy (Evidence: Moderate 1).
  • For patients with propionic acidaemia presenting with extrapyramidal symptoms, L-DOPA may be effective for symptom management (Evidence: Weak 1).
  • References

    1 Burlina AP, Baracchini C, Carollo C, Burlina AB. Propionic acidaemia with basal ganglia stroke: treatment of acute extrapyramidal symptoms with L-DOPA. Journal of inherited metabolic disease 2001. link

    Original source

    1. [1]
      Propionic acidaemia with basal ganglia stroke: treatment of acute extrapyramidal symptoms with L-DOPA.Burlina AP, Baracchini C, Carollo C, Burlina AB Journal of inherited metabolic disease (2001)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG